Inventor · disambiguated record
Hans-Dieter Volk
Also filed as: VOLK HANS-DIETER
15 granted patents·18 pending applications·93 citations·filing 1982–2022
90Inventor score
Files withUNIV BERLIN CHARITE8AICURIS GMBH & CO KG5KERN FLORIAN4CHARITE UNIVERSITAETSMEDIZIN2VOLK HANS DIETER2
Top patents by PatentIndex Score
33 records- 0188US7718425B2Use of a B-cell-depleting antibody for treatment of polyoma virus infectionsCHARITE UNIVERSIT UMLAUT OVER·Filed 2007·Granted May 18, 2010·48 cites·22 claims
- 0278US8357363B2Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefromAICURIS GMBH & CO KG·Filed 2002·Granted Jan 22, 2013·5 cites·4 claims
- 0378US7041442B1Peptides for vaccinating against human CMVKERN FLORIAN·Filed 2000·Granted May 9, 2006·19 cites·8 claims
- 0469US9763985B2Antigen-specific central-memory T cell preparations having high CD4+ fractionVOLK HANS-DIETER·Filed 2012·Granted Sep 19, 2017·1 cites·8 claims
- 0569US9714272B2Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefromAICURIS GMBH & CO KG·Filed 2014·Granted Jul 25, 2017·0 cites·11 claims
- 0669US2019292231A1Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefromAICURIS GMBH & CO KG·Filed 2019·Application pending·0 cites
- 0767US2023033136A1Cd8+t-cell subsets as markers for prediction of delayed fracture healingUNIV BERLIN CHARITE·Filed 2022·Application pending·0 cites
- 0862US2017320918A1Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefromAICURIS GMBH & CO KG·Filed 2017·Application pending·0 cites
- 0961US8852577B2Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefromAICURIS GMBH & CO KG·Filed 2012·Granted Oct 7, 2014·0 cites·10 claims
- 1061US7994096B2Method for antigen-specific stimulation of T lymphocytes with synthetic peptide librariesKERN FLORIAN·Filed 2001·Granted Aug 9, 2011·7 cites·13 claims
- 1157US2023406903A1Reprogramming immune cells by targeted integration of zeta-deficient chimeric antigen receptor transgenesUNIV BERLIN CHARITE·Filed 2021·Application pending·0 cites
- 1256US2024066061A1A cxcr3+ cell or cell preparation for use in cancer treatmentUNIV BERLIN CHARITE·Filed 2022·Application pending·0 cites
- 1354US8673934B2Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accidentMEISEL ANDREAS·Filed 2003·Granted Mar 18, 2014·2 cites·9 claims
- 1453US11639935B2CD8+T-cell subsets as markers for prediction of delayed fracture healingUNIV BERLIN CHARITE·Filed 2019·Granted May 2, 2023·0 cites·2 claims
- 1552US2009197851A1Therapy and use of compounds in therapyMAX DELBRUECK CENTRUM·Filed 2008·Application pending·0 cites
- 1652US2007197485A1Therapy and Use of Compounds in TherapyMAX DELBRUECK CT FUR MOLEKULAR·Filed 2007·Application pending·0 cites
- 1752US2023174936A1Immunosuppressant-resistant t-cells for adoptive immunotherapyUNIV BERLIN CHARITE·Filed 2021·Application pending·0 cites
- 1849US8617560B2Peptides for vaccination against human CMVKERN FLORIAN·Filed 2006·Granted Dec 31, 2013·0 cites·19 claims
- 1949US2007042967A1Proteaseome inhibitors for the treatment of herpesviridae infected individualsCHARITE UNIVERSITAETSMEDIZIN·Filed 2006·Application pending·0 cites
- 2049US2021364495A1Crispr associated protein reactive t cell immunityUNIV BERLIN CHARITE·Filed 2020·Application pending·0 cites
- 2147US2002119571A1Genetically modified T-cells, method for producing them and use thereofFiled 2002·Application pending·0 cites
- 2246US2015010924A1Cd8+t-cell subsets as markers for prediction of delayed fracture healingCHARITÈ UNIVERSITÄTSMEDIZIN BERLIN·Filed 2013·Application pending·0 cites
- 2345US2008044403A1Immune Markers Used for Diagnosis and Therapy in Connection With Transplant ReactionsSAWITZKI BIRGIT·Filed 2003·Application pending·0 cites
- 2444US2005171022A1Proteaseome inhibitors for the treatment of herpesviridae infected individualsCHARITE UNIVERSITAETSMEDIZIN·Filed 2003·Application pending·0 cites
- 2542US2013143223A1Method of determining kidney transplantation toleranceHERNANDEZ-FUENTES MARIA·Filed 2011·Application pending·0 cites
- 2642US2010254958A1Antigen-Specific T-Cell Preparations from Bone MarrowLETSCH ANNE·Filed 2008·Application pending·0 cites
- 2738US2020197341A1Immunmodulation for prevention of poor healing of musculoskeletal injuries in compromised patientsUNIV BERLIN CHARITE·Filed 2018·Application pending·0 cites
- 2835US11802873B2CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgeryUNIV BERLIN CHARITE·Filed 2018·Granted Oct 31, 2023·0 cites·7 claims
- 2935US2016153994A1Ebv proteins as markers in methods of diagnosing chronic fatigue syndrome (cfs)JPT PEPTIDE TECHNOLOGIES GMBH·Filed 2014·Application pending·0 cites
- 3033US4424798ASelf-heatable containerVOLK HANS DIETER·Filed 1982·Granted Jan 10, 1984·9 cites·10 claims
- 3125US10144777B2B-lymphocyte targeting agents for use in a method for the treatment of a diseaseTSCHOEPE CARSTEN·Filed 2010·Granted Dec 4, 2018·0 cites·21 claims
- 3224US8932806B1Method for identifying t-cell stimulating protein fragmentsKERN FLORIAN·Filed 1999·Granted Jan 13, 2015·1 cites·8 claims
- 3317US5656601AAcylated splenopentins, methods for their synthesis and their useBERLIN CHEMIE AG·Filed 1991·Granted Aug 12, 1997·1 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →